Separation process of unconventional communicable causal agents from protein solution
HK1009277A1
Process to prepare an anti-d immunoglobulin g concentrate and pharmaceutical compositions comprising it
DE19831061A1
Reducing aggregate content of protein preparation, especially virus-inactivated therapeutic plasma protein or chemically modified protein preparation
US5912328A
Method for the removal of viruses from protein solutions
CN1223686A
Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
EP0865792A1
Pharmaceutical composition containing immunoglobulin for topical use
EP0835880A1
Process for producing an IgM preparation for intravenous administration
TW388763B
Method of producing a hyper immunoglobulin preparation from fractions produced druing fractionation of human blood plasma
EP0793970A1
Photodynamic inactivation of viruses
US5652339A
Method of producing reconstituted lipoproteins
EP0679405A1
Method for separating viruses from protein solutions
CH684164A5
Immunoglobulin solution which can be administered intravenously
EP0409057A1
Device for injection fluid administration or body liquid removal
CA1335077C
Process for the manufacture of apolipoproteins from human blood plasma or serum
